Adverse Event Assessment of Upadacitinib: A Pharmacovigilance Study Based on the FAERS Database

Documenti analoghi

• Adverse Events Associated With Dabrafenib, Trametinib, and Their Combination Therapy: A Disproportionality Analysis of the FDA Adverse Event Reporting System ( FAERS ) Database
  di: Zhenpo Zhang, et al.
  Pubblicazione: (2025)
• A Real‐World Pharmacovigilance Study of FDA Adverse Event Reporting System Events for Obeticholic Acid
  di: Le Hai, et al.
  Pubblicazione: (2025)
• A Real‐World Study on Adverse Reactions of Belimumab Based on the FDA Adverse Event Reporting System Database
  di: Le Hai, et al.
  Pubblicazione: (2024)
• Aioli: Standardising Drugs in the FDA Adverse Event Reporting System ( FAERS ) to RxNorm and Anatomical Therapeutic Chemical ( ATC ) Codes
  di: Rowan E. Parry, et al.
  Pubblicazione: (2025)
• Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug Events
  di: W. N. Kelly, et al.
  Pubblicazione: (2024)